LSE - Delayed Quote GBp
Hemogenyx Pharmaceuticals Plc (HEMO.L)
178.00
-0.75
(-0.42%)
At close: 4:10:42 PM GMT+1
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Operating Cash Flow
-4,140.06
-4,140.06
-6,105.57
-2,910.60
-2,627.30
Investing Cash Flow
-1.73
-1.73
-31.94
-420.25
-938.95
Financing Cash Flow
3,077.45
3,077.45
4,449.31
-110.14
8,777.64
End Cash Position
159.27
159.27
1,247.60
2,532.76
6,840.97
Capital Expenditure
-13.29
-13.29
-117.29
-428.95
-818
Issuance of Capital Stock
3,712.49
3,712.49
5,088.08
0
0
Issuance of Debt
--
--
--
0
12,000
Repayment of Debt
--
--
--
0
-3,183.28
Free Cash Flow
-4,153.34
-4,153.34
-6,222.86
-3,339.55
-3,445.30
12/31/2021 - 11/9/2015
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
6C1.BE CytomX Therapeutics Inc
1.7720
-15.54%
N04.MU Nucana PLC R
0.0445
+30.88%
226950.KQ OliX Pharmaceuticals, Inc
46,350.00
+4.86%
6C1.SG CytomX Therapeutics Inc
2.0420
-1.54%
N04.SG Nucana PLC (ADRs)
0.0310
+19.23%
0A45.IL Moderna, Inc.
23.53
-3.78%
N04.F NuCana plc
0.0300
+200.00%
N04.BE Nucana PLC R
0.0845
+10.46%
6C1.F CytomX Therapeutics, Inc.
2.0700
+0.88%
PYC.L Physiomics Plc
0.4250
0.00%